查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1853479

抗凝血滅鼠劑市場按類型、劑型、作用機制、目標囓齒動物種類、最終用戶和應用分類－全球預測，2025-2032年

Anticoagulant Rodenticides Market by Type, Formulation, Mode Of Action, Target Rodent, End User, Application Method - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，抗凝血滅鼠劑市場規模將成長 29.6 億美元，複合年成長率為 13.99%。

關鍵市場統計數據
基準年2024年 10.3億美元
預計年份：2025年 11.8億美元
預測年份 2032 29.6億美元
複合年成長率（%） 13.99%

這份簡明扼要的介紹面向相關人員，概述了影響抗凝血滅鼠劑市場格局的關鍵問題、監管壓力和科學複雜性。

抗凝血滅鼠劑市場是一個錯綜複雜的領域，涉及化學、生態學、監管環境和商業性需求等許多面向。從製劑生產商和農民到市政害蟲防治項目和住房服務提供商，相關人員必須應對不斷變化的關於藥效和抗藥性的科學證據、日益成長的環境管理期望，以及日益重視非目標生物保護和上市後監測的法規環境。

在此背景下，有效的推廣至關重要：滅鼠劑不僅僅是產品類型，而是一套涵蓋毒理學、應用方法、物種行為和供應鏈可靠性的綜合實踐系統。活性成分化學和製劑技術的最新進展正在改變操作預期，而應用基礎設施（例如誘餌站設計和防篡改投放）的相應發展趨勢，則將價值重心轉移到綜合服務產品上。

因此，決策者在選擇產品和設計方案時，應重點關注活性成分的選擇、作用機制、目標囓齒動物的生物學特性以及最終用戶的需求之間的兼容性。這項觀點確立了本報告的核心前提：使抗凝血劑的技術特性與價值鏈中各相關人員的監管要求和優先事項保持一致，才能實現持久的害蟲防治效果。

對價值鏈中產品開發、阻力動態、環境政策和相關人員期望等方面的變革性轉變進行了深刻剖析。

抗凝血滅鼠劑市場正經歷技術、監管和市場主導的變革時期。分子毒理學和監測技術的進步提高了對亞致死效應和二次暴露途徑的檢測能力，促使監管機構和採購商重新評估可接受的風險閾值。同時，囓齒類抗藥性模式的顯著變化也迫使產品開發商重新評估其優先考慮的化學品類型以及其上市產品所配套的管理措施。

隨著科學的進步，採購行為也不斷演變。大型農業和市政採購商越來越要求提供可驗證的環境保障措施、減少非目標生物暴露的證據以及供應鏈透明度。因此，供應商正致力於配方創新，以提高偏好和目標生物的靶向性，同時最大限度地減少環境殘留。此外，數位化監測和誘餌站遙測技術的整合正在重塑服務模式，使其朝向基於結果的合約模式轉變，在這種模式下，有效性指標和事件報告是商業性關係的核心。

總而言之，這些轉變正在創造一種新的競爭動態。能夠將可靠的毒理學數據、負責任的應用系統和清晰的監管路徑相結合的組織，將更有利於贏得長期合約並主導舉措。在這種環境下，對科學發現的快速回應和積極參與法律規範不再是可選項，而是商業性韌性的基石。

對2025年美國累積關稅措施及其對抗凝血滅鼠劑企業的營運、供應鏈和合規影響進行重點分析

美國在2025年前實施的累積關稅政策對製造業、分銷業和應用服務業產生了直接且連鎖的影響。進口成本的增加促使一些經銷商重新評估其供應商多元化策略，尋求更靠近產地的原料和成品，以降低貿易政策波動帶來的風險。同時，關稅也改變了採購時機，許多買家在保單生效前加快採購，而另一些買家則尋求與多家供應商簽訂合約以分散風險。

在營運方面，關稅凸顯了供應鏈透明度和合約彈性的重要性。擁有更緊密的公司間物流、更強的國內製造能力和長期供應商協議的企業受到的衝擊較小，而依賴單一來源進口的企業則面臨更大的庫存和利潤壓力。此外，與商品分類、文件編制和海關通訊協定相關的合規成本也迫使監管、採購和商務團隊更加緊密地合作，以避免運輸延誤和潛在的執法行動。

從策略角度來看，關稅環境提升了情境規劃的價值，包括對投入成本波動的敏感度、緊急採購計劃，以及審查配方方案以便在監管和療效允許的情況下進行替代。決策者現在將貿易政策視為影響成本結構以及產品上市、註冊續約和監管計畫部署時間表的關鍵因素。

以數據主導的細分洞察，將類型、配方、作用機制、目標物種、最終用戶和應用方法轉化為決策者的策略重點。

有效的策略細分始於產品類型，並將技術屬性轉化為營運優先事項。與第二代抗凝血劑（Chlorophacinone、Coumatetralyl靈、敵鼠鈉鹽、敵鼠鈉鹽、Warfarin）相比，第一代抗凝血劑（氯鼠靈、Bromadiolone、敵鼠鈉鹽、Difethialone鼠Flocoumafen）的療程往往較短，且用藥管理模式也不同。這種差異會影響抗藥性管理、環境暴露以及最終用戶的選擇。

所研究的製劑——塊狀、顆粒狀、液體狀、糊狀和丸劑——每種製劑都有獨特的應用和偏好特徵，從而影響產品的使用地點和方式。作用機制分類闡明了生化標靶：香豆素類藥物——溴敵隆、Bromadiolone靈、Coumatetralyl、Difethialone酮、Flocoumafen、氟香豆素和Warfarin——與茚滿二酮類藥物——Chlorophacinone、二鼠靈和吡啶酮——形成對比。

目標物種細分——以小鼠、大鼠、松鼠和田鼠為目標——決定了製劑選擇和施用方法，因為物種特異性的攝食和棲息地行為決定了最佳施用效果。最終用戶細分——農業、商業、工業、市政和居民區——決定了監管暴露、可接受的殘留特徵和管理預期。最後，對誘餌站、洞穴誘餌、液體誘餌和散裝誘餌等施用方法的探索——塑造了操作規程和風險管理框架。整合這些方面，建立了一個以細分為主導的框架，支援差異化的產品定位和有針對性的風險緩解策略。

整合美洲、歐洲、中東和非洲以及亞太市場的需求促進因素、管理體制和物流限制的區域情報

區域動態對管理體制、營運風險和商業策略有重大影響。在美洲，相關人員需要在強勁的農業需求和日益嚴格的環境審查之間尋求平衡。採購往往優先考慮營運可靠性和成本效益，而監管機構則強調非目標影響的緩解和事故報告。因此，供應鏈強調快速分銷、本地化技術支援以及符合聯邦和州政府要求的管理計劃。

歐洲、中東和非洲的監管體系各不相同，其中許多規定都涉及環境持久性和二次暴露。這種差異性要求提供細緻的監管資訊和量身定做的產品管理措施。許多歐洲、中東和非洲地區的司法管轄區都非常重視監測和報告，製造商通常需要根據不同國家的標準調整標籤檢視、可接受的配方和應用指南。因此，這些地區的市場准入取決於監管機構的積極回應和相關人員的持續參與。

在亞太地區，快速的都市化、多樣化的農業實踐以及日益成長的糧食安全擔憂推動了需求成長，並影響著可接受的管理實踐。供應鏈物流在不同地區可能有顯著差異，商業公司必須考慮分銷基礎設施的差異以及執法力度的差異。在所有地區，成功的策略都取決於技術能力與當地監管要求和最終用戶偏好的契合度，同時保持靈活性以應對特定地區的突發事件管理需求。

對抗凝血滅鼠劑領域中推動創新、管理和商業策略的主要企業進行競爭概況和能力評估

抗凝血滅鼠劑領域的競爭地位取決於活性成分和配方創新、完善的監管管理系統、監管專業知識以及分銷能力。領先企業持續投入產品監管、透明的環境風險溝通，並與施用器和市政採購人員夥伴關係，以在整個價值鏈中貫徹最佳實踐。這種做法有助於降低聲譽風險，並支持以可衡量的監管成果為依據的長期合約。

除了技術領先之外，商業性差異化往往源自於一體化服務模式。提供捆綁式解決方案的供應商，例如將最佳化配方與誘餌站基礎設施、監測服務和培訓相結合的供應商，能夠與重視結果保障的大型機構買家建立密切合作關係。同樣，那些建立嚴謹的內部合規團隊並積極與監管機構溝通的公司，可以加快註冊續期流程，並在司法管轄區變更時協助完成標籤變更。

分銷策略同樣至關重要。擁有多元化物流、區域倉儲以及與農業合作社和市政採購部門建立強大管道的公司，往往能在貿易中斷時期保持更高的供應能力和應對力。最終，競爭優勢在於那些將科學信譽、卓越營運、強力的管理以及調整商業模式以適應不斷變化的法規和買家期望的能力相結合的企業。

提出切實可行的、優先考慮的建議，以降低監管風險、最佳化配方、加強管理，並使商業模式與永續性要求保持一致。

行業領導者應採取一系列優先行動，將監管意識和科學知識轉化為營運韌性和商業性優勢。首先，應建立一個跨職能的監管委員會，將毒理學、法規事務、供應鏈和銷售部門聯繫起來，以確保配方選擇、標籤更新和應用指南在不同司法管轄區保持一致。這種一體化的管治將縮短合規時間，並有助於向買家和監管機構傳遞一致的通訊。

第二，透過採購多元化和增強供應合約的靈活性，降低關稅和貿易政策帶來的風險。盡可能投資本地製造業和戰略夥伴關係關係，以減少對易受影響的進口管道的依賴。第三，加速採用精準投放系統和基於實證的應用通訊協定，以減少非目標物種的暴露，並支持與監管機構的有效溝通。投資誘餌站遠端檢測和經過驗證的監測通訊協定，可以展現可衡量的成果，並吸引機構投資者的注意。

第四，優先與監管機構和最終用戶進行透明溝通，並公佈管理數據和事件回應程序。這種透明度有助於建立信任，並降低受到懲罰的可能性。最後，在功效和法律規範允許的情況下，探索低殘留配方，並設計培訓計劃，確保不同最終用戶群正確應用，從而使商業性產品與永續發展目標保持一致。這些措施共同打造了永續性的市場地位，同時滿足了日益影響採購決策的環境和監管優先事項。

對調查方法、資料來源和分析框架的清晰闡述，確保了研究的嚴謹性和可重複性，並為相關人員提供決策層面的洞見。

這些研究成果結合了定性和定量方法，以確保分析的嚴謹性和可重複性。主要分析包括對毒理學、產品開發、法規事務和害蟲管理領域的專家進行訪談，以了解實際操作情況和新出現的挑戰。次要分析則綜合了同儕審查文獻、官方監管文件和技術指導文件，以揭示活性成分的行為、抗藥性報告和最佳管理實踐。

本研究採用的分析框架包括：產品比較分析，旨在將活性成分屬性與生態學持久性和非目標風險相匹配；細分分析，旨在將應用方法與物種行為聯繫起來；以及情境規劃，旨在評估不同貿易政策環境下供應鏈的韌性。數據檢驗透過多資訊來源三角驗證和專家專案評審來實現，以確保分析結果反映當前的行業實踐。

我們始終強調調查方法假設和限制的透明度。在摘要各司法管轄區的監管細節時，調查方法會關注不同的方法，並著重指出需要進行本地諮詢的領域。這種調查方法的選擇既有助於提供決策層面的洞見，又能認知到在敏感的監管情況下需要進行針對特定司法管轄區的後續跟進。

這是一份綜合分析報告，它將監管、技術、商業和區域等各個方面聯繫起來，為行業領導者和政策制定者提供切實可行的建議。

我們的總結報告綜合考慮了監管趨勢、技術差異、供應鏈現狀和區域差異，旨在強調價值鏈各環節領導者必須關注的要點。首先，科學發展和抗藥性監測凸顯了持續投資於活性成分管理和應用創新的重要性。其次，貿易政策的變化和關稅壓力表明，供應鏈設計和採購的靈活性是一項策略要務，它直接影響商業性可行性。

第三，更清晰的市場區隔——按產品類型、配方、作用機制、目標物種、最終用戶和應用方法分類——能夠實現更精準的產品定位和風險規避。第四，區域動態凸顯了市場准入和持續推廣需要細緻的監管資訊和在地化的營運模式。綜上所述，這些發現預示著該產業未來的發展方向是：將功效、環境管理、監管參與和供應鏈韌性視為相互融合的優先事項，而非各自獨立的工作。

因此，決策者應優先考慮跨職能協作，投資遠端檢測和監控，並追求供應商多元化和區域營運能力，以此作為策略支柱，使組織能夠應對當前的合規挑戰，並在政策和生態學條件不斷變化的情況下保持持續的領導地位。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 增加可生物分解的抗凝血滅鼠劑餌料的開發，以實現永續的害蟲防治
  • 囓齒類動物對第一代Warfarin抗凝血劑產生抗藥性，促使相關研究和開發工作加速進行。
  • 透過整合物聯網智慧監測系統最佳化抗凝血誘餌投放。
  • 美國環保署收緊對溴敵隆的限制將鼓勵向風險較低的活性成分替代品過渡。
  • 生物防治和化學防治相結合的綜合蟲害管理策略正得到越來越廣泛的應用
  • 商用滅鼠劑電子商務分銷的增加正在擾亂傳統的供應鏈。
  • 奈米封裝技術的開發旨在提高抗凝血劑的穩定性和靶向釋放。
  • 都市區寵物飼養趨勢推動了對寵物安全型抗凝血滅鼠劑的需求激增

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 抗凝血滅鼠劑市場（按類型分類）

  • 第一代
    • Chlorophacinone
    • Coumatetralyl
    • 敵鼠酮
    • 皮多內
    • Warfarin
  • 第二代
    • Brodifacoum
    • Bromadiolone
    • 敵敵畏
    • Difethialone
    • Flocoumafen

9. 依配方分類的抗凝血滅鼠劑市場

  • 堵塞
  • 糧食
  • 液體
  • 貼上
  • 顆粒

第10章：抗凝血滅鼠劑市場依作用機制分類

  • 香豆素
    • Brodifacoum
    • Bromadiolone
    • Coumatetralyl
    • 敵敵畏
    • Difethialone
    • Flocoumafen
    • Warfarin
  • 印丹吉翁
    • Chlorophacinone
    • 敵鼠酮
    • 皮多內

第11章 抗凝血滅鼠劑市場目標囓齒動物

  • 老鼠
  • 鼠
  • 松鼠
  • 田鼠

第12章 依最終用戶分類的抗凝血滅鼠劑市場

  • 農業
  • 商業的
  • 產業
  • 市政
  • 住宅

第13章 依應用分類的抗凝血滅鼠劑市場

  • 誘餌站
  • 洞穴覓食
  • 液體餌料
  • 散餌

第14章 抗凝血滅鼠劑市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 抗凝血滅鼠劑市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 各國抗凝血滅鼠劑市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • BASF SE
    • Bayer AG
    • Neogen Corporation
    • PelGar International PLC
    • Syngenta AG
    • FMC Corporation
    • UPL Limited
    • Adama Agricultural Solutions Ltd.
    • Sumitomo Chemical Co., Ltd.
    • Sichuan Sunshine Biotech Co., Ltd.
Product Code: MRR-3A2E844FF1DD

The Anticoagulant Rodenticides Market is projected to grow by USD 2.96 billion at a CAGR of 13.99% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.03 billion
Estimated Year [2025] USD 1.18 billion
Forecast Year [2032] USD 2.96 billion
CAGR (%) 13.99%

A concise introduction framing the critical issues, regulatory pressures, and scientific complexities shaping the anticoagulant rodenticide landscape for stakeholders

The anticoagulant rodenticide landscape presents a complex intersection of chemistry, ecology, regulatory scrutiny, and commercial necessity. Stakeholders ranging from formulators and agricultural operators to municipal pest-control programs and residential service providers must navigate evolving scientific evidence on efficacy and resistance, increasing expectations for environmental stewardship, and a tightening regulatory environment that emphasizes non-target protection and post-market monitoring.

Against this backdrop, an effective introduction reframes the conversation: rodenticides are not solely a product category but a system of practices that couples toxicology with application method, species behavior, and supply chain reliability. Recent advances in active ingredient chemistry and formulation technology have altered operational expectations, while parallel developments in application infrastructure-such as bait-station design and tamper-resistant delivery-have shifted the locus of value toward integrated service offerings.

Consequently, decision-makers should approach product selection and program design with an emphasis on compatibility among active ingredient selection, mode of action, target rodent ecology, and end-user needs. This introductory perspective establishes the central premise of the report: durable pest management outcomes derive from aligning technical properties of anticoagulant solutions with regulatory requirements and stakeholder priorities across the value chain.

An incisive review of transformative shifts redefining product development, resistance dynamics, environmental policy, and stakeholder expectations across the value chain

The landscape for anticoagulant rodenticides is undergoing transformative shifts that are simultaneously technical, regulatory, and market-driven. Advances in molecular toxicology and surveillance have sharpened detection of sublethal effects and secondary exposure pathways, prompting regulators and purchasers to reassess acceptable risk thresholds. At the same time, documented changes in rodent resistance patterns have driven product developers to re-evaluate both the chemical scaffolds they prioritize and the stewardship measures they bundle with commercial offerings.

Parallel to these scientific drivers, procurement behavior is evolving. Large agricultural and municipal buyers increasingly demand demonstrable environmental safeguards, evidence of reduced non-target exposure, and supply chain transparency. As a result, suppliers are investing in formulation innovations that enhance palatability and targeted delivery while minimizing environmental persistence. In addition, integration of digital monitoring and bait-station telemetry is reshaping service models toward outcome-based contracts where efficacy metrics and incident reporting are central to commercial relationships.

Taken together, these shifts are creating new competitive dynamics: organizations that can link robust toxicological profiles with responsible application systems and clear regulatory pathways will be better positioned to capture long-term contracts and to lead stewardship initiatives. In this environment, responsiveness to scientific findings and proactive engagement with regulatory frameworks are no longer optional but foundational to commercial resilience.

A focused analysis of cumulative United States tariff measures enacted in 2025 and their operational, supply chain, and compliance consequences for anticoagulant rodenticide operators

The introduction of cumulative tariff measures in the United States during 2025 has had immediate and cascading implications for operators across manufacturing, distribution, and application services. Increased import costs have prompted some distributors to reassess vendor diversification and to seek nearer-sourced ingredients or finished goods to reduce exposure to trade policy volatility. In parallel, tariffs have shifted procurement timing, with many buyers accelerating purchases ahead of policy milestones and others exploring multi-supplier contracts to spread risk.

Operationally, tariffs have emphasized the importance of supply chain visibility and contractual flexibility. Companies with tighter intercompany logistics, domestic manufacturing capabilities, or long-term supplier agreements have experienced fewer disruptions, while those reliant on single-source imports have faced heightened inventory and margin pressures. Additionally, compliance costs associated with classification, documentation, and customs protocols have required closer collaboration between regulatory, procurement, and commercial teams to avoid shipment delays and potential enforcement actions.

From a strategic standpoint, the tariff environment has reinforced the value of scenario planning: sensitivity to input-cost fluctuation, contingency sourcing plans, and revisiting formulation options to allow substitution where regulatory and efficacy considerations permit. Decision-makers now view trade policy as a material factor that affects not only cost structures but also timelines for product launches, registration renewals, and stewardship program rollouts.

Data-driven segmentation insights that translate type, formulation, mode of action, target species, end user, and application method into strategic priorities for decision makers

Effective strategic segmentation requires translating technical attributes into operational priorities, beginning with product type. First Generation anticoagulants-studied across Chlorophacinone, Coumatetralyl, Diphacinone, Pindone, and Warfarin-tend to be associated with shorter persistence and different stewardship profiles compared with Second Generation agents, which are studied across Brodifacoum, Bromadiolone, Difenacoum, Difethialone, and Flocoumafen and often present greater potency and persistence considerations. This dichotomy has implications for resistance management, environmental exposure, and end-user selection.

Formulation choices further refine strategy; formulations studied across Blocks, Grain, Liquid, Paste, and Pellets each carry unique application and palatability characteristics that influence where and how products are deployed. The mode of action categorization clarifies biochemical targeting: Coumarin compounds-further studied across Brodifacoum, Bromadiolone, Coumatetralyl, Difenacoum, Difethialone, Flocoumafen, and Warfarin-contrast with Indanedione agents-further studied across Chlorophacinone, Diphacinone, and Pindone-in terms of metabolic pathways and implications for resistance monitoring.

Target species segmentation across Mice, Rats, Squirrels, and Voles drives both formulation selection and application method, because species-specific foraging and habitat behaviors determine optimal delivery. End-user segmentation across Agricultural, Commercial, Industrial, Municipal, and Residential contexts dictates regulatory exposure, acceptable residual profiles, and stewardship expectations. Finally, application methods studied across Bait Stations, Burrow Baiting, Liquid Baiting, and Loose Bait shape operational protocols and risk management frameworks. Integrating these dimensions yields a segmentation-led framework that supports differentiated product positioning and targeted risk mitigation strategies.

Regional intelligence synthesizing demand drivers, regulatory regimes, and logistical constraints across the Americas, Europe, Middle East & Africa, and the Asia-Pacific markets

Regional dynamics materially influence regulatory posture, operational risk, and commercial strategies. In the Americas, stakeholders operate in jurisdictions that balance robust agricultural demand with growing environmental scrutiny; procurement tends to prioritize operational reliability and cost-effectiveness, while regulators emphasize non-target impact mitigation and incident reporting. Consequently, supply chains emphasize responsive distribution, localized technical support, and stewardship programs that align with both federal and state-level expectations.

Across Europe, Middle East & Africa, regulatory regimes are diverse and often more prescriptive regarding environmental persistence and secondary exposure. This heterogeneity necessitates granular regulatory intelligence and tailored product stewardship measures. In many EMEA jurisdictions, there is heightened emphasis on monitoring and reporting, and manufacturers frequently need to adapt labeling, allowable formulations, and application guidance to meet disparate national standards. Market access here is therefore dependent on regulatory agility and sustained stakeholder engagement.

In the Asia-Pacific region, demand drivers include rapid urbanization, diverse agricultural practices, and an increasing focus on food security that shapes acceptable control practices. Supply chain logistics can vary widely across the region, and commercial players must account for disparate distribution infrastructure and differing enforcement intensity. Across all regions, successful strategies hinge on aligning technical performance with local regulatory expectations and end-user preferences, while maintaining the flexibility to respond to region-specific incident management requirements.

Competitive profiling and capability assessment of leading companies driving innovation, stewardship, and commercial strategy within the anticoagulant rodenticide sector

Competitive positioning within the anticoagulant rodenticide sector is shaped by a combination of innovation in active ingredients and formulations, strength of stewardship programs, regulatory expertise, and distribution capabilities. Leading organizations demonstrate consistent investment in product stewardship, transparent environmental risk communication, and partnerships with applicators and municipal buyers to embed best practices across the value chain. This approach reduces reputational risk and supports longer-term contracts that hinge on measurable stewardship outcomes.

In addition to technical leadership, commercial differentiation often arises from integrated service models. Suppliers that offer bundled solutions-combining optimized formulation with bait-station infrastructure, monitoring services, and training-achieve closer alignment with large institutional buyers who prioritize outcome assurance. Similarly, companies that cultivate rigorous internal compliance teams and proactive regulatory engagement can accelerate registration updates and smoothly navigate label changes required by jurisdictional shifts.

Distribution strategy also matters: firms with diversified logistics, regional warehouses, and strong channels into agricultural cooperatives and municipal procurement tend to maintain higher availability and responsiveness during periods of trade disruption. Ultimately, competitive advantage accrues to organizations that marry scientific credibility with operational excellence, robust stewardship, and the ability to adapt commercial models to evolving regulatory and buyer expectations.

Actionable, prioritized recommendations to mitigate regulatory risk, optimize formulations, strengthen stewardship, and align commercial models with sustainability imperatives

Industry leaders should adopt a set of prioritized actions that translate regulatory awareness and scientific insight into operational resilience and commercial advantage. First, establish cross-functional stewardship committees that link toxicology, regulatory affairs, supply chain, and sales to ensure that formulation choices, labeling updates, and application guidance remain aligned across jurisdictions. This integrated governance reduces time-to-compliance and supports consistent messaging to buyers and regulators.

Second, diversify sourcing and build flexibility into supply contracts to mitigate tariff and trade-policy exposure. Where feasible, invest in regional manufacturing or strategic partnerships that reduce reliance on vulnerable import routes. Third, accelerate adoption of targeted delivery systems and evidence-based application protocols that reduce non-target exposure and support favorable regulatory engagement. Investing in bait-station telemetry and validated monitoring protocols can demonstrate measurable outcomes that appeal to institutional buyers.

Fourth, prioritize transparent communication with regulators and end-users by publishing stewardship data and incident-response procedures. Such transparency builds trust and reduces the likelihood of punitive actions. Finally, align commercial offerings with sustainability objectives by exploring lower-persistence formulations where efficacy and regulatory frameworks permit, and by designing training programs that ensure correct field application across diverse end-user groups. Collectively, these actions create a defensible market position while addressing the environmental and regulatory priorities that increasingly determine procurement decisions.

Clear exposition of the research methodology, data sources, and analytical frameworks used to ensure rigor, reproducibility, and decision-grade insights for stakeholders

The research underpinning these insights combines qualitative and quantitative approaches designed to ensure analytical rigor and reproducibility. Primary methods include interviews with technical experts across toxicology, product development, regulatory affairs, and pest management practitioners to capture operational realities and emergent challenges. Secondary analysis integrates peer-reviewed literature, public regulatory filings, and technical guidance documents to contextualize active-ingredient behavior, resistance reporting, and stewardship best practices.

Analytical frameworks applied in this work include comparative product profiling that maps active ingredient properties to ecological persistence and non-target risk, segmentation analysis linking application method to species behavior, and scenario planning to evaluate supply chain resilience under alternative trade-policy environments. Data validation is achieved through triangulation across multiple sources and targeted expert review to ensure that interpretations reflect current industry practice.

Throughout, emphasis was placed on transparency of assumptions and methodological limitations. Where jurisdictional regulatory detail is summarized, the methodology notes the range of approaches and highlights areas where local consultation is required. These methodological choices support decision-grade insights while acknowledging the need for jurisdiction-specific follow-up in regulatory-sensitive contexts.

A concluding synthesis that connects regulatory, technical, commercial, and regional threads into pragmatic conclusions for industry leaders and policymakers

The concluding synthesis draws together regulatory trends, technical differentiation, supply chain realities, and regional nuance into a focused set of takeaways for leaders across the value chain. First, scientific developments and resistance monitoring underscore the need for ongoing investment in active-ingredient stewardship and application innovation. Second, trade-policy shifts and tariff pressures demonstrate that supply chain design and sourcing flexibility are now strategic imperatives that directly affect commercial viability.

Third, segmentation clarity-across type, formulation, mode of action, target species, end user, and application method-enables more precise product positioning and risk mitigation. Fourth, regional dynamics affirm that granular regulatory intelligence and localized operational models are essential for market access and sustained uptake. Taken together, these threads point toward an industry future where efficacy, environmental stewardship, regulatory engagement, and supply chain resilience are integrated priorities rather than separate initiatives.

Decision-makers should therefore prioritize cross-functional alignment, invest in telemetry and monitoring, and pursue supplier diversification and regional operational capabilities as core strategic pillars. By doing so, organizations can both meet immediate compliance challenges and position themselves for sustained leadership as policy and ecological conditions continue to evolve.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Increased development of biodegradable anticoagulant rodenticide baits for sustainable pest control
  • 5.2. Emergence of rodent populations resistant to first-generation warfarin anticoagulants driving R&D
  • 5.3. Integration of IoT-enabled smart monitoring systems to optimize anticoagulant bait deployment
  • 5.4. Stricter EPA regulations on brodifacoum trigger shift toward low-risk active ingredient alternatives
  • 5.5. Rising adoption of integrated pest management strategies combining biological and chemical controls
  • 5.6. Growth in e-commerce distribution of professional-grade rodenticides impacting traditional supply chains
  • 5.7. Development of nano-encapsulation technologies enhancing anticoagulant stability and targeted release
  • 5.8. Surge in demand for pet-safe anticoagulant rodenticides driven by urban pet ownership trends

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Anticoagulant Rodenticides Market, by Type

  • 8.1. First Generation
    • 8.1.1. Chlorophacinone
    • 8.1.2. Coumatetralyl
    • 8.1.3. Diphacinone
    • 8.1.4. Pindone
    • 8.1.5. Warfarin
  • 8.2. Second Generation
    • 8.2.1. Brodifacoum
    • 8.2.2. Bromadiolone
    • 8.2.3. Difenacoum
    • 8.2.4. Difethialone
    • 8.2.5. Flocoumafen

9. Anticoagulant Rodenticides Market, by Formulation

  • 9.1. Blocks
  • 9.2. Grain
  • 9.3. Liquid
  • 9.4. Paste
  • 9.5. Pellets

10. Anticoagulant Rodenticides Market, by Mode Of Action

  • 10.1. Coumarin
    • 10.1.1. Brodifacoum
    • 10.1.2. Bromadiolone
    • 10.1.3. Coumatetralyl
    • 10.1.4. Difenacoum
    • 10.1.5. Difethialone
    • 10.1.6. Flocoumafen
    • 10.1.7. Warfarin
  • 10.2. Indanedione
    • 10.2.1. Chlorophacinone
    • 10.2.2. Diphacinone
    • 10.2.3. Pindone

11. Anticoagulant Rodenticides Market, by Target Rodent

  • 11.1. Mice
  • 11.2. Rats
  • 11.3. Squirrels
  • 11.4. Voles

12. Anticoagulant Rodenticides Market, by End User

  • 12.1. Agricultural
  • 12.2. Commercial
  • 12.3. Industrial
  • 12.4. Municipal
  • 12.5. Residential

13. Anticoagulant Rodenticides Market, by Application Method

  • 13.1. Bait Stations
  • 13.2. Burrow Baiting
  • 13.3. Liquid Baiting
  • 13.4. Loose Bait

14. Anticoagulant Rodenticides Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Anticoagulant Rodenticides Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Anticoagulant Rodenticides Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. BASF SE
    • 17.3.2. Bayer AG
    • 17.3.3. Neogen Corporation
    • 17.3.4. PelGar International PLC
    • 17.3.5. Syngenta AG
    • 17.3.6. FMC Corporation
    • 17.3.7. UPL Limited
    • 17.3.8. Adama Agricultural Solutions Ltd.
    • 17.3.9. Sumitomo Chemical Co., Ltd.
    • 17.3.10. Sichuan Sunshine Biotech Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FORMULATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MODE OF ACTION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MODE OF ACTION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TARGET RODENT, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TARGET RODENT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY APPLICATION METHOD, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY APPLICATION METHOD, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. ANTICOAGULANT RODENTICIDES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. ANTICOAGULANT RODENTICIDES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ANTICOAGULANT RODENTICIDES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FIRST GENERATION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FIRST GENERATION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FIRST GENERATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FIRST GENERATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FIRST GENERATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FIRST GENERATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FIRST GENERATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FIRST GENERATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY CHLOROPHACINONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY CHLOROPHACINONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY CHLOROPHACINONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY CHLOROPHACINONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY CHLOROPHACINONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY CHLOROPHACINONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMATETRALYL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMATETRALYL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMATETRALYL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMATETRALYL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMATETRALYL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMATETRALYL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIPHACINONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIPHACINONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIPHACINONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIPHACINONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIPHACINONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIPHACINONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PINDONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PINDONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PINDONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PINDONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PINDONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PINDONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY WARFARIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY WARFARIN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY WARFARIN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY WARFARIN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY WARFARIN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY WARFARIN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SECOND GENERATION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SECOND GENERATION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SECOND GENERATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SECOND GENERATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SECOND GENERATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SECOND GENERATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SECOND GENERATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SECOND GENERATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BRODIFACOUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BRODIFACOUM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BRODIFACOUM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BRODIFACOUM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BRODIFACOUM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BRODIFACOUM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BROMADIOLONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BROMADIOLONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BROMADIOLONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BROMADIOLONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BROMADIOLONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BROMADIOLONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFENACOUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFENACOUM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFENACOUM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFENACOUM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFENACOUM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFENACOUM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFETHIALONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFETHIALONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFETHIALONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFETHIALONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFETHIALONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFETHIALONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FLOCOUMAFEN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FLOCOUMAFEN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FLOCOUMAFEN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FLOCOUMAFEN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FLOCOUMAFEN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FLOCOUMAFEN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BLOCKS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BLOCKS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BLOCKS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BLOCKS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BLOCKS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BLOCKS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY GRAIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY GRAIN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY GRAIN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY GRAIN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY GRAIN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY GRAIN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY LIQUID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY LIQUID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY LIQUID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY LIQUID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PASTE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PASTE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PASTE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PASTE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PASTE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PASTE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PELLETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PELLETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PELLETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PELLETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PELLETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PELLETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MODE OF ACTION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMARIN, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMARIN, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMARIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMARIN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMARIN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMARIN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMARIN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMARIN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BRODIFACOUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BRODIFACOUM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BRODIFACOUM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BRODIFACOUM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BRODIFACOUM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BRODIFACOUM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BROMADIOLONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BROMADIOLONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BROMADIOLONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BROMADIOLONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BROMADIOLONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BROMADIOLONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMATETRALYL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMATETRALYL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMATETRALYL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMATETRALYL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMATETRALYL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMATETRALYL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFENACOUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFENACOUM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFENACOUM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFENACOUM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFENACOUM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFENACOUM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFETHIALONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFETHIALONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFETHIALONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFETHIALONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFETHIALONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIFETHIALONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FLOCOUMAFEN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FLOCOUMAFEN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FLOCOUMAFEN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FLOCOUMAFEN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FLOCOUMAFEN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FLOCOUMAFEN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY WARFARIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY WARFARIN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY WARFARIN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY WARFARIN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY WARFARIN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY WARFARIN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDANEDIONE, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDANEDIONE, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDANEDIONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDANEDIONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDANEDIONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDANEDIONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDANEDIONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDANEDIONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY CHLOROPHACINONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY CHLOROPHACINONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY CHLOROPHACINONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY CHLOROPHACINONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY CHLOROPHACINONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY CHLOROPHACINONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIPHACINONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIPHACINONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIPHACINONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIPHACINONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIPHACINONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY DIPHACINONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PINDONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PINDONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PINDONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PINDONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PINDONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY PINDONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TARGET RODENT, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TARGET RODENT, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MICE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MICE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MICE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MICE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MICE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MICE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY RATS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY RATS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY RATS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY RATS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY RATS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY RATS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SQUIRRELS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SQUIRRELS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SQUIRRELS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SQUIRRELS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SQUIRRELS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SQUIRRELS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY VOLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY VOLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY VOLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY VOLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY VOLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY VOLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY AGRICULTURAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY AGRICULTURAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY AGRICULTURAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY AGRICULTURAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY AGRICULTURAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY AGRICULTURAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COMMERCIAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COMMERCIAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COMMERCIAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COMMERCIAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COMMERCIAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COMMERCIAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDUSTRIAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDUSTRIAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDUSTRIAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDUSTRIAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDUSTRIAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDUSTRIAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MUNICIPAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MUNICIPAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MUNICIPAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MUNICIPAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MUNICIPAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MUNICIPAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY RESIDENTIAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY RESIDENTIAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY RESIDENTIAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY RESIDENTIAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY RESIDENTIAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY RESIDENTIAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY APPLICATION METHOD, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BAIT STATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BAIT STATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BAIT STATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BAIT STATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BAIT STATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BAIT STATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BURROW BAITING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BURROW BAITING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BURROW BAITING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BURROW BAITING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BURROW BAITING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY BURROW BAITING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY LIQUID BAITING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY LIQUID BAITING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY LIQUID BAITING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY LIQUID BAITING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY LIQUID BAITING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY LIQUID BAITING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY LOOSE BAIT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY LOOSE BAIT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY LOOSE BAIT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY LOOSE BAIT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY LOOSE BAIT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY LOOSE BAIT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL ANTICOAGULANT RODENTICIDES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 279. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 280. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 281. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 282. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 283. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FIRST GENERATION, 2018-2024 (USD MILLION)
  • TABLE 284. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FIRST GENERATION, 2025-2032 (USD MILLION)
  • TABLE 285. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SECOND GENERATION, 2018-2024 (USD MILLION)
  • TABLE 286. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SECOND GENERATION, 2025-2032 (USD MILLION)
  • TABLE 287. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 288. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 289. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
  • TABLE 290. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY MODE OF ACTION, 2025-2032 (USD MILLION)
  • TABLE 291. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMARIN, 2018-2024 (USD MILLION)
  • TABLE 292. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUMARIN, 2025-2032 (USD MILLION)
  • TABLE 293. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDANEDIONE, 2018-2024 (USD MILLION)
  • TABLE 294. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY INDANEDIONE, 2025-2032 (USD MILLION)
  • TABLE 295. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TARGET RODENT, 2018-2024 (USD MILLION)
  • TABLE 296. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TARGET RODENT, 2025-2032 (USD MILLION)
  • TABLE 297. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 298. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 299. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 300. AMERICAS ANTICOAGULANT RODENTICIDES MARKET SIZE, BY APPLICATION METHOD, 2025-2032 (USD MILLION)
  • TABLE 301. NORTH AMERICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 302. NORTH AMERICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 303. NORTH AMERICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 304. NORTH AMERICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 305. NORTH AMERICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FIRST GENERATION, 2018-2024 (USD MILLION)
  • TABLE 306. NORTH AMERICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FIRST GENERATION, 2025-2032 (USD MILLION)
  • TABLE 307. NORTH AMERICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SECOND GENERATION, 2018-2024 (USD MILLION)
  • TABLE 308. NORTH AMERICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY SECOND GENERATION, 2025-2032 (USD MILLION)
  • TABLE 309. NORTH AMERICA ANTICOAGULANT RODENTICIDES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)

TABL